Quinolone antibacterial drugs inhibit bacterial DNA helicase and have a broad-spectrum antibacterial effect. They have strong antibacterial activity against Enterobacter bacteria such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc., as well as influenza bacillus and Neisseria. They also have certain antibacterial effects on Staphylococcus aureus and Pseudomonas aeruginosa. They have only mild effects on pneumococci, various groups of streptococci and enterococci.

This product is a nucleoside derivative, which promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. In addition, it can enhance the function of the ascending activation system of the brainstem reticular structure, enhance the function of the pyramidal system, and improve motor paralysis, so it has a certain effect on promoting the recovery of brain function and promoting awakening.

It promotes lipid metabolism, increases energy production, improves energy supply to tissues and organs, increases the activity of NADH cytochrome C reductase and cytochrome oxidase, accelerates the production of ATP, and participates in drug detoxification; other functions include the oxidation of medium-chain fatty acids, the oxidation of fatty acid peroxidase, the buffering effect on the ratio of bound coenzyme A to free coenzyme A, the generation of energy from ketones, pyruvate, and amino acids (including branched-chain amino acids), the removal of excessive coenzyme A toxicity, and the regulation of blood ammonia concentration.

It promotes the synthesis of bone-derived growth factors (such as BMPs, TGF-beta, FGF, etc.), regulates bone metabolism, stimulates osteoblast proliferation, promotes new bone formation, regulates calcium-phosphorus metabolism, increases bone calcium deposition, and has anti-inflammatory and analgesic effects.

It reduces the permeability of local capillaries in fractures, reduces inflammatory exudation, promotes blood circulation recovery, improves the local blood supply environment of bone callus, inhibits the release of prostaglandins to achieve analgesic effects, and synergizes with polypeptide bone metabolic factors to promote early healing of fractures.

Provide raw materials for bone cells to synthesize bone-derived biological factors and promote the synthesis of bone-derived biological factors.

Participates in calcium and phosphorus metabolism and maintains bone volume.

Participates in calcium and phosphorus metabolism and maintains bone volume.

Participates in calcium and phosphorus metabolism and maintains bone volume.

Supports physiological functions related to bone metabolism and calcium-phosphorus metabolism.

This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria, and has antibacterial effects on most bacteria of the Enterobacteriaceae family, penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella, Pseudomonas aeruginosa, etc. It has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial effects on Chlamydia trachomatis, Mycoplasma, and Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. It has poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibits DNA synthesis and replication, and causes bacterial death.